HomeCompareRCC vs MRK

RCC vs MRK: Dividend Comparison 2026

RCC yields 5.74% · MRK yields 3.25%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $9.3K in total portfolio value
10 years
RCC
RCC
● Live price
5.74%
Share price
$25.04
Annual div
$1.44
5Y div CAGR
-34.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.5K
Annual income
$8.56
Full RCC calculator →
MRK
Merck & Co. Inc.
● Live price
3.25%
Share price
$94.80
Annual div
$3.08
5Y div CAGR
8.2%
Payout ratio
42%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$950.29
Full MRK calculator →

Portfolio growth — RCC vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRCCMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RCC + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RCC pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RCC
Annual income on $10K today (after 15% tax)
$487.98/yr
After 10yr DRIP, annual income (after tax)
$7.28/yr
MRK
Annual income on $10K today (after 15% tax)
$276.16/yr
After 10yr DRIP, annual income (after tax)
$807.75/yr
At 15% tax rate, MRK beats the other by $800.47/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RCC + MRK for your $10,000?

RCC: 50%MRK: 50%
100% MRK50/50100% RCC
Portfolio after 10yr
$26.1K
Annual income
$479.43/yr
Blended yield
1.84%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

RCC
No analyst data
Altman Z
0.0
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+35.6% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RCC buys
0
MRK buys
0
No recent congressional trades found for RCC or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRCCMRK
Forward yield5.74%3.25%
Annual dividend / share$1.44$3.08
Payout ratio50%42%
1-year div growth0%5.5%
5-year div CAGR-34.9%8.2%
Portfolio after 10y$21.5K$30.7K
Annual income after 10y$8.56$950.29
Total dividends collected$1.1K$6.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: RCC vs MRK ($10,000, DRIP)

YearRCC PortfolioRCC Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$11,074$373.74$11,192$351.54$118.00MRK
2$12,101$251.80$12,524$392.70$423.00MRK
3$13,115$167.41$14,015$438.65$900.00MRK
4$14,144$110.39$15,682$489.96$1.5KMRK
5$15,206$72.43$17,547$547.23$2.3KMRK
6$16,318$47.38$19,632$611.16$3.3KMRK
7$17,491$30.93$21,963$682.53$4.5KMRK
8$18,736$20.17$24,571$762.18$5.8KMRK
9$20,060$13.15$27,486$851.08$7.4KMRK
10$21,473$8.56$30,745$950.29$9.3KMRK

RCC vs MRK: Complete Analysis 2026

RCCStock

Ready Capital Corp. is a real estate finance company, which engages in acquiring, managing, and financing small balance commercial loans. It operates through the following segments: SBC Lending and Acquisitions, Small Business Lending, and Residential Mortgage Banking. The SBC Lending and Acquisitions segment is involved in the SBC loans across the full life-cycle of an SBC property including construction, bridge, stabilized, and agency loan origination channels through wholly-owned subsidiary, ReadyCap Commercial, LLC. The Small Business Lending segment acquires, originates, and services owner-occupied loans guaranteed by the SBA under its SBA Section 7(a) Program through wholly-owned subsidiary, ReadyCap Lending, LLC. The Residential Mortgage Banking segment focuses on the residential mortgage loan origination segment through wholly-owned subsidiary, GMFS, LLC. The company was founded in November 2011 and is headquartered in New York, NY.

Full RCC Calculator →

MRKHealthcare

Merck is a Dividend Aristocrat with 14+ consecutive years of increases. Keytruda (pembrolizumab) is the world's best-selling cancer drug and drives exceptional cash generation. The company's oncology and vaccines pipeline provides long-term growth visibility beyond the Keytruda patent cliff in the 2030s.

Full MRK Calculator →
📬

Get this RCC vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RCC vs SCHDRCC vs JEPIRCC vs ORCC vs KORCC vs MAINRCC vs JNJRCC vs ABBVRCC vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.